Spaser as a biological probe

Understanding cell biology greatly benefits from the development of advanced diagnostic probes. Here we introduce a 22-nm spaser (plasmonic nanolaser) with the ability to serve as a super-bright, water-soluble, biocompatible probe capable of generating stimulated emission directly inside living cell...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 8; no. 1; p. 15528
Main Authors Galanzha, Ekaterina I., Weingold, Robert, Nedosekin, Dmitry A., Sarimollaoglu, Mustafa, Nolan, Jacqueline, Harrington, Walter, Kuchyanov, Alexander S., Parkhomenko, Roman G., Watanabe, Fumiya, Nima, Zeid, Biris, Alexandru S., Plekhanov, Alexander I., Stockman, Mark I., Zharov, Vladimir P.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 08.06.2017
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Understanding cell biology greatly benefits from the development of advanced diagnostic probes. Here we introduce a 22-nm spaser (plasmonic nanolaser) with the ability to serve as a super-bright, water-soluble, biocompatible probe capable of generating stimulated emission directly inside living cells and animal tissues. We have demonstrated a lasing regime associated with the formation of a dynamic vapour nanobubble around the spaser that leads to giant spasing with emission intensity and spectral width >100 times brighter and 30-fold narrower, respectively, than for quantum dots. The absorption losses in the spaser enhance its multifunctionality, allowing for nanobubble-amplified photothermal and photoacoustic imaging and therapy. Furthermore, the silica spaser surface has been covalently functionalized with folic acid for molecular targeting of cancer cells. All these properties make a nanobubble spaser a promising multimodal, super-contrast, ultrafast cellular probe with a single-pulse nanosecond excitation for a variety of in vitro and in vivo biomedical applications. Advanced diagnostic probes are required for monitoring disease progression. Here Galanzha et al . demonstrate a 22 nm plasmonic nanolaser to serve as a super-bright, biocompatible probe capable of generating stimulated emission directly inside living cells and animal tissue, while targeting cancer cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/ncomms15528